US FDA Asks For Public Input On Software It Can't Regulate

FDA is writing a report on key safety impacts from health software products that fall outside of its regulatory purview under the 21st Century Cures Act. To help the effort, the agency is asking industry, patient groups and other stakeholders to chime in by June 28.

More from Digital Technologies

More from Medtech Insight